Effect of anti-interleukin 12 treatment on murine lyme borreliosis

Journal of Clinical Investigation

Volumn 97, Issue 4, 1996, Pages 1028-1034

  Anguita, Juan ^a   Persing, David H ^b   Rincón, Mercedes ^a   Barthold, Stephen W ^a   Fikrig, Erol ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

arthritis; Borrelia burgdorferi; cytokines; mice; Th1 response

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 12 ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HELPER CELL; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LYME DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029863566     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118494     Document Type: Article

References (47)

1. Malawista, S.E. 1992. Lyme disease. In Cecil's Textbook of Medicine. 19th ed. W B Saunders, editor, Philadelphia, PA. 1772-1777.
2. Steere, A.C., N.H. Bartenhagen, J.E. Craft, G.J. Hutchinson, J.H. Newman, D.W. Rahn, L.H. Sigal. P.H Spieler, K.S. Stenn, and S.E. Malawista. 1983. The early clinical manifestations of Lyme disease. Ann Intern. Med. 99, 76-82
3. Steere, A.C., W.P Batsford, M Weinberg, J. Alexander, H.J. Berger, S. Wolfson, and S.E. Malawista. 1980. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 93:8-16.
4. Steere, A.C., A. Gibofsky, M E. Patarroyo, R.J. Winchester, J.A. Hardin, and S E. Malawista. 1979. Chronic Lyme arthritis: clinical and immunogenic differentiation from rheumatoid arthritis. Ann Intern. Med. 90:286-291.
5. Anderson, J.F., S.W. Barthold, and L.A. Magnarelli. 1990. Infectious but non pathogenic isolate of Borrelia burgdorferi J. Clin. Microbiol 28:2693-2699.
6. Kalish, R.A., J.M Leong, and A.C. Steere. 1993. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun. 61:2774-2779.
7. Steere, A.C., E. Dwyer, and R. Winchester. 1990. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl J. Med 323: 219-223.
8. Shanafelt, M.C., J. Anzola, C. Soderberg, H. Yssel, C W. Turck, and G. Peltz. 1992 Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease. J. Immunol. 148:218-224.
9. Yssel, H., T. Nakamoto, P. Schneider, V Freitas, C. Collins, D. Webb, N. Mensi, C. Soderberg, and G. Peltz. 1990. Analysis of T lymphocytes cloned from the synovial fluid and blood of a patient with Lyme arthritis. Int. Immunol. 2.1081-1089.
10. Yssel, H., M Shanafelt, C. Soderberg, P.V. Schneider, J. Anzola, and G. Peltz. 1991. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme Arthritis. J. Exp. Med 174:593-601
11. Barthold, S.W., D.S. Beck, G M. Hansen, G.A. Terwilliger, and D. Moody. 1990 Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162:133-138.
12. Schaible, U.E., M D. Kramer, R. Wallich, T. Tran, and M M Simon 1991. Experimental Borrelta burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur. J Immunol 21.2397-2405.
13. Yang, L., J.H. Weis, E. Eichwald, C.P. Kolbert, D.H. Persing, and J J. Weis. 1994. Heritable susceptibility to severe Borrelta burgdurferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun 62:492-500.
14. Yang, L., Y. Ma, R. Schoenfeld, M. Griffiths, E Eichwald, B. Araneo, and J.J. Weis. 1992. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect Immun. 60:3033-3041.
15. Matyniak, J.E , and S.L. Reiner. 1995 T helper phenotype and susceptibility in experimental Lyme disease. J. Exp. Med. 181:1251-1254.
16. Brunda, M.J. 1994. Interleukin-12. J. Leukocyte Biol, 55:280-288.
17. Kobayashi, M., L. Fitz, M Ryan, R.M Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Tnnchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp. Med 170:827-845.
18. Stern, A.S., F.J. Podlaski, J D. Hulmes, Y.E. Pan, P.M Quinn, A.G. Wolitzky, P.C. Familletti, D L Stremlo, T. Truitt. R Chizzonite, and M.K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad Sci. USA. 87:6808-6812.
19. Vicira, L Q., B.D. Hondowicz, L C. Afonso, M. Wysocka, G. Trinchieri, and P Scott 1994. Infection with Letshmania major induces interleukm-12 production in vivo Immunol Lett. 40:157-161.
20. Gazzinelli, R T , M. Wysocka, S. Hayashi, E Y. Denkers, S Hieny, P Caspar, G Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates eaily IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153:2533-2543.
21. Radolf, J.D., L L. Arndt, D.R. Akins, L.L. Curetty, M.E. Levi, Y. Shen, L.S. Davis, and M.V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866-2877
22. Chang, S.H., M Kobayashi, D. Santoli, B. Perussia, and G. Trinchieri. 1992 Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF and II.-2. J Immunol. 148:92-98.
23. Manetti, R , P Parronchi, M.G. Guidizi, M.P. Piccini, E. Maggi, G Trinchieri. and S. Romagnani. 1993. Natural killer cell stimulatory factor interleukin 12 (IL-12) induces T helper type 1 (Tn1)-specific immune responses and inhibits the development of IL-4 producingTh cells. J. Exp. Med. 177:1199-1204.
24. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells Immunol. Today. 14:335-338.
25. Barthold, S.W., M.S. de Souza, J.L. Janotka, A.L. Smith, and D.H. Persing. 1993. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143 959-971.
26. Barbour, A.G. 1984 Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57.521-525.
27. Fikrig, E., H. Tao, F.S. Kantor, S.W. Barthold, and R.A. Flavell. 1993. Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B. Proc Natl. Acad. Sci. USA 90:4092-4096.
28. Fikrig, E., S.W. Barthold, F.S. Kantor, and R.A. Flavell. 1992. Long term protection of mice from Lyme disease by immunizing with recombinant OspA. Infect. Immun. 60:773-778.
29. Fikrig, E., S.W. Barthold, and R.A. Flavell. 1993. OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect Immun. 61:2553-2558.
30. Barthold, S.W., D.H. Persing, A.L. Armstrong, and R.A. Peeples. 1991. Kinetics of Borrelia burgdorferi: dissemination and evolution of disease following intradermal inoculation of mice. Am. J Pathol. 163:263-273.
31. Malawista, S.E., S.W. Barthold, and D.H. Persing. 1994. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J. Infect. Dis. 170:1312-1316.
32. Persing, D.H., B.J. Rutledge, P.N. Rys, D.S. Podzorski, P.D. Mitchell, K.D. Reed, B. Liu. E. Fikrig, and S.E. Malawista 1994. Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect. Dis. 169:668-672.
33. Barthold, S.W , E. Fikrig, L.K. Bockendtedt, and D.H. Persing. 1995. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect. Immun. 63 2255-2261.
34. Fikrig, E., S W. Barthold, F.S. Kantor, and R.A. Flavell. 1990. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science (Wash. DC). 250:553-556.
35. Fikrig, E., S.W. Barthold, N. Marcantonio, K. Deponte, F.S. Kantor, and R.A. Flavell. 1992. Roles of OspA, OspB. and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. Immun. 59:553-559.
36. Steere, A.C. 1989. Lyme disease. N. Engl. J. Med. 9:586 596.
37. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, S. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not IFN-γ production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909-915.
38. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S.F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153: 5167-5175.
39. + T cells requires the coordinate action of interleukin-12 and IFN-γ and is inhibited by transforming growth factor β. Eur. J. Immunol. 24:793-798.
40. Hsieh, C., S.E. Macatonia, A. O'garra, and K.M. Murphy. 1995. T cell helper background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713-721.
41. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp Med. 180-211-222.
42. Murphy, E.E., G. Terres, S.E. Macatonia, C. Hsieh, J Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and IFN-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180 223-231.
43. Skeen, M.J., and H.K. Ziegler. 1995. Activation of γδ T cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J. Immunol. 154:5832-5841.
44. Radolf, J.D., M.V. Norgard, M.E. Brandt, R.D. Isaacs, P.A. Thompson, and B Beutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. J. Immunol 147:1968-1974.
45. Hunter, C.A , C.S. Subauste, V.H. Van Cleave, and J S. Remington. 1994. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice, regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect, immun. 62:2818-2824.
46. Lahesmaa, R , M.C. Shanafelt, A. Allsup, C Soderberg, J. Anzola, V. Freitas. C. Turck, L. Steinman, and G Peltz. 1993. Preferential usage of T cell antigen receptor V region gene segment Vp 5.1 by Borrelia burgdorfert antigen-reactive T cell clones isolated from a patient with Lyme disease. J Immunol. 150:4125-4135.
47. D'Orazio, J.A., G.W. Burke, and J. Streilein. 1995. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-γ but requires T lymphocytes to augment NK cytotoxicity J Immunol. 154:1014-1023.